Track Record of Identifying Rare Wealth CreatorsTrack Record of Identifying Rare Wealth Creators
Manish Goel - SEBI Registered Investment Adviser

About Manish Goel

SEBI Registered Investment Adviser • Chartered Accountant

420 Articles Published

Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

March 16, 2026
Header with title 'Titan Biotech 50x Deep Dive' and a horizontal bar chart for FY20–FY25; values 28, 26, 22, 18, 14, 11; FY25 bar is green.

Titan Biotech 50x Deep Dive: Complete Value Investing Analysis — How ₹8 Became ₹400

📅 Published March 16, 2026 (Monday) https://multibaggershares.com/wp-content/uploads/2026/03/titan_biotech_value_investing_deepdive_english.mp4 A comprehensive 6-minute deep dive into one of India’s most remarkable multibagger stories. Titan Biotech Limited (BSE: 524717) delivered […]
March 16, 2026
Titan Biotech header with subtitle; horizontal bar chart shows yearly values from FY20 to FY25: FY20 28, FY21 26, FY22 22, FY23 18, FY24 14, FY25 11 (green).

Titan Biotech: From ₹8 to ₹400 — The 50x Multibagger Story | Value Investing #Shorts

📅 Published March 16, 2026 (Monday) https://multibaggershares.com/wp-content/uploads/2026/03/titan_biotech_50x_english_short.mp4 Titan Biotech (BSE: 524717) turned ₹8 into ₹400 — a stunning 50x multibagger return! Learn the 3 key factors […]
March 16, 2026
Hero section: article title about Rupee until ₹93/$; subtitle in italics; includes a horizontal bar chart showing FY20–FY25 values, with the final bar highlighted in green (11 in FY25).

Rupee at ₹93/$ — Why This Is a Golden Opportunity for Pharma & Biotech Investors

The Indian Rupee has depreciated to ~93 per US Dollar. While headlines scream doom, smart investors see this as a powerful tailwind for India's $30B+ pharma export engine. India is the Pharmacy of the World — and a weaker rupee makes it even more competitive. Here's why pharma & biotech stocks are the biggest beneficiaries.
March 16, 2026
Hero header with the title 'Economic Moats' and green subtitle on a dark blue background; a two-by-two color block grid labeled Trader (gray), COMPUNDER (green), Drift (light gray), Speculator (orange); footer credit text.

Economic Moats: How to Find Companies That Competitors Simply Cannot Destroy

📅 Published March 16, 2026 (Monday) Table of Contents Toggle What Is an Economic Moat? The Five Types of Economic Moats 1. Cost Advantage Moat 2. […]
+91-7380122211